{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:00:08Z","timestamp":1771624808111,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Dr Reddy's Laboratories"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40119-021-00239-1","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T09:02:56Z","timestamp":1630746176000},"page":"429-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of Amlodipine in Stroke and Myocardial infarction: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"10","author":[{"given":"Shamanna S.","family":"Iyengar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish Chander","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumitra","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Srinivasa","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Yunus","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha Rani H.","family":"Patted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumar","family":"Gaurav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,4]]},"reference":[{"key":"239_CR1","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44:2064\u201389.","journal-title":"Stroke"},{"key":"239_CR2","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1056\/NEJM199511233332106","volume":"23","author":"LL Bronner","year":"1995","unstructured":"Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med. 1995;23:1392\u2013400.","journal-title":"N Engl J Med"},{"key":"239_CR3","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(00)03306-7","volume":"356","author":"M Pahor","year":"2000","unstructured":"Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line anti-hypertensive therapies: a meta-analysis of randomized controlled trials. Lancet. 2000;356:1949\u201354.","journal-title":"Lancet"},{"key":"239_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/00004872-200306000-00002","volume":"21","author":"JA Staessen","year":"2003","unstructured":"Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until March 1st 2003. J Hypertens. 2003;21:1055\u201376.","journal-title":"J Hypertens"},{"key":"239_CR5","doi-asserted-by":"crossref","unstructured":"Williams B, Mancia G, Spiering W, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 2018;39(33):3021\u2013104.","DOI":"10.1093\/eurheartj\/ehy439"},{"key":"239_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/jcbfm.1989.20","volume":"9","author":"BK Siesjo","year":"1989","unstructured":"Siesjo BK, Bengtsson F. Calcium fluxes, calcium antagonists and calcium-related pathology in brain ischemia, hypoglycemia and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab. 1989;9:127\u201340.","journal-title":"J Cereb Blood Flow Metab"},{"key":"239_CR7","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/0024-3205(94)00391-2","volume":"55","author":"A Rami","year":"1994","unstructured":"Rami A, Krieglstein J. Neuronal protective effects of calcium antagonists in cerebral ischemia. Life Sci. 1994;55:2105\u201313.","journal-title":"Life Sci"},{"issue":"4","key":"239_CR8","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/01.STR.0000126208.14181.DD","volume":"35","author":"CM Lawes","year":"2004","unstructured":"Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35(4):1024\u201333.","journal-title":"Stroke"},{"key":"239_CR9","doi-asserted-by":"crossref","unstructured":"Gueyffier F, Boissel JP, Boutitie F et al. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke. 1997;28(12):2557\u201362.","DOI":"10.1161\/01.STR.28.12.2557"},{"issue":"1","key":"239_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.107.089763","volume":"50","author":"JG Wang","year":"2007","unstructured":"Wang JG, Li Y, Franklin SS, Safar M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers. A quantitative overview. Hypertension. 2007;50(1):181\u20138.","journal-title":"Hypertension"},{"key":"239_CR11","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/0735-1097(88)92608-3","volume":"12","author":"J Schofer","year":"1988","unstructured":"Schofer J, Spielmann R, Schuchert A, Weber K, Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988;12:1252\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"239_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1291\/hypres.30.815","volume":"30","author":"S Nagahama","year":"2007","unstructured":"Nagahama S, Norimatsu T, Maki T, et al. The effect of combination therapy with an L\/N-Type Ca(2+) channel blocker, cilnidipine, and an angiotensin II receptor blocker on the blood pressure and heart rate in Japanese hypertensive patients: an observational study conducted in Japan. Hypertens Res. 2007;30:815\u201322.","journal-title":"Hypertens Res"},{"issue":"7","key":"239_CR13","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/archinte.1989.00390070171030","volume":"149","author":"AE Skolnick","year":"1989","unstructured":"Skolnick AE, Frishman WH. Calcium channel blockers in myocardial infarction. Arch Intern Med. 1989;149(7):1669\u201377.","journal-title":"Arch Intern Med"},{"key":"239_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahl\u00f6f","year":"2005","unstructured":"Dahl\u00f6f B, Sever PS. Prevention of cardiovascular events with an anti-hypertensive regimen of Amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet. 2005;366:895\u2013906.","journal-title":"Lancet"},{"issue":"4 Suppl 1","key":"239_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1524-6175.2005.04446.x","volume":"7","author":"WJ Elliott","year":"2005","unstructured":"Elliott WJ, Bandari A. The role of calcium antagonists in stroke prevention. J Clin Hypertens (Greenwich). 2005;7(4 Suppl 1):5\u20138.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7521","key":"239_CR16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1136\/bmj.38595.518542.3A","volume":"331","author":"MA McDonald","year":"2005","unstructured":"McDonald MA, Simpson SH, Ezekowitz JA, Gyenes G, Tsuyuki RT. Angiotensin receptor blockers and risk of myocardial infarction: systematic review. BMJ. 2005;331(7521):873.","journal-title":"BMJ"},{"issue":"42","key":"239_CR17","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1093\/eurheartj\/ehz896","volume":"41","author":"R Pavasini","year":"2020","unstructured":"Pavasini R, et al. Complete revascularisation reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials. Eur Heart J. 2020;41(42):4103\u201310.","journal-title":"Eur Heart J"},{"issue":"18","key":"239_CR18","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","volume":"292","author":"SE Nissen","year":"2004","unstructured":"Nissen SE, Tuzcu EM, Libby P, et al. Effect of anti-hypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004;292(18):2217\u201325.","journal-title":"JAMA"},{"issue":"22","key":"239_CR19","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/CIRCULATIONAHA.117.026112","volume":"135","author":"MH Strauss","year":"2017","unstructured":"Strauss MH, Hall AS. Angiotensin receptor blockers do not reduce risk of myocardial infarction, cardiovascular death, or total mortality: further evidence for the ARB-MI paradox. Circulation. 2017;135(22):2088\u201390.","journal-title":"Circulation"},{"issue":"23","key":"239_CR20","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the anti-hypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288(23):2981\u201397.","journal-title":"JAMA"},{"key":"239_CR21","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0895-7061(02)03000-5","volume":"15","author":"G Leonetti","year":"2002","unstructured":"Leonetti G, Magnani B, Pessina AC, et al. Tolerability of long-term treatment with lercanidipine versus Amlodipine and lacidipine in elderly hypertensives. Am J Hypertens. 2002;15:932\u201340.","journal-title":"Am J Hypertens"},{"key":"239_CR22","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/00004872-200305000-00026","volume":"21","author":"P Lund-Johansen","year":"2003","unstructured":"Lund-Johansen P, Stranden E, Helberg S, et al. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. J Hypertens. 2003;21:1003\u201310.","journal-title":"J Hypertens"},{"key":"239_CR23","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417\u201328.","journal-title":"N Engl J Med"},{"key":"239_CR24","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","volume":"363","author":"S Julius","year":"2004","unstructured":"Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet. 2004;363:2022\u201331.","journal-title":"Lancet"},{"key":"239_CR25","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1093\/ndt\/gfn304","volume":"23","author":"M Tepel","year":"2008","unstructured":"Tepel M, Hopfenmueller W, Scholze A, Maier A, Zidek W. Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients. Nephrol Dial Transplant. 2008;23:3605\u201312.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"239_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/joim.13170","volume":"289","author":"I Kalar","year":"2021","unstructured":"Kalar I, Xu H, Secnik J, et al. Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study. J Intern Med. 2021;289(4):508\u201322.","journal-title":"J Intern Med"},{"issue":"6","key":"239_CR27","first-page":"502","volume":"34","author":"Y Li","year":"2018","unstructured":"Li Y, Zhong Z, Luo S, et al. Efficacy of anti-hypertensive therapy in the acute stage of cerebral infarction\u2014a prospective, randomized control trial. Acta Cardiol Sin. 2018;34(6):502\u201310.","journal-title":"Acta Cardiol Sin"},{"issue":"7","key":"239_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.7326\/0003-4819-138-7-200304010-00010","volume":"138","author":"T Berl","year":"2003","unstructured":"Berl T, Hunsicker LG, Lewis JB, et al. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med. 2003;138(7):542\u20139.","journal-title":"Ann Intern Med"},{"issue":"13","key":"239_CR29","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/01.cir.102.13.1503","volume":"102","author":"B Pitt","year":"2000","unstructured":"Pitt B, Byington RP, Furberg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation. 2000;102(13):1503\u201310. https:\/\/doi.org\/10.1161\/01.cir.102.13.1503.","journal-title":"Circulation"},{"issue":"3","key":"239_CR30","first-page":"64","volume":"66","author":"M Tiwaskar","year":"2018","unstructured":"Tiwaskar M, Langote A, Kashyap R, Toppo A. Amlodipine in the era of new generation calcium channel blockers. J Assoc Physicians India. 2018;66(3):64\u20139.","journal-title":"J Assoc Physicians India"},{"issue":"5","key":"239_CR31","doi-asserted-by":"publisher","first-page":"FC01","DOI":"10.7860\/JCDR\/2017\/23825.9763","volume":"11","author":"K Shetty","year":"2017","unstructured":"Shetty K, Shetty R, Bairy L, et al. A comparative study on clinical and biochemical parameters in amlodipine and cilnidipine treated hypertensive patients. J Clin Diagn Res. 2017;11(5):FC01\u20135. https:\/\/doi.org\/10.7860\/JCDR\/2017\/23825.9763.","journal-title":"J Clin Diagn Res"},{"key":"239_CR32","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","volume":"113","author":"The CAFE Investigators","year":"2006","unstructured":"The CAFE Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213\u201325.","journal-title":"Circulation"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-021-00239-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-021-00239-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-021-00239-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T15:30:36Z","timestamp":1635435036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-021-00239-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1007\/s40119-021-00239-1","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,4]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}